2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
This biotech player is firing on all cylinders.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.